---
$id: https://graph.org.ai/products/commodity/51286705
$type: Product
source: UNSPSC
code: "51286705"
title: "Ormetoprim"
class: "51286700"
classTitle: "Antibacterial pyrimidines"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ormetoprim

**UNSPSC Code**: 51286705
**Class**: [Antibacterial pyrimidines](Antibacterial pyrimidines.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a dihydrofolate reductase inhibitor with the molecular formula C14H18N4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M3EFS94984, chemically known as 2,4-pyrimidinediamine, 5-((4,5-dimethoxy-2-methylphenyl)methyl)- but more generally known as ormetoprim, which bears US NIH Compound Identifier 23418. European Medicines Agency schedules Ormetoprim in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09463MIG. The term ORMETOPRIM is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 23, No. 10 1969, List 9). ORMETOPRIM is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1CC(CC2C(NC(NC2)N)N)C(CC1OC)C)C.

